Literature DB >> 20032981

Nanomedicine: barcodes check out prostate cancer.

Stephen Hearty, Paul Leonard, Richard O'Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20032981     DOI： 10.1038/nnano.2009.459

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN： 1748-3387            Impact factor:   39.213


× No keyword cloud information.
  5 in total

1.  Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors:  Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ziding Feng; Howard L Parnes; Charles A Coltman
Journal:  J Natl Cancer Inst       Date:  2006-04-19       Impact factor: 13.506

Review 2.  Biosensor developments: application to prostate-specific antigen detection.

Authors:  Declan A Healy; Conor J Hayes; Paul Leonard; Louise McKenna; Richard O'Kennedy
Journal:  Trends Biotechnol       Date:  2007-01-24       Impact factor: 19.536

3.  Screening for prostate cancer--the controversy that refuses to die.

Authors:  Michael J Barry
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

4.  Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy.

Authors:  C Shad Thaxton; Robert Elghanian; Audrey D Thomas; Savka I Stoeva; Jae-Seung Lee; Norm D Smith; Anthony J Schaeffer; Helmut Klocker; Wolfgang Horninger; Georg Bartsch; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

Review 5.  Prostate specific antigen recurrence after definitive therapy.

Authors:  Stephen J Freedland; Judd W Moul
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450
  5 in total
  2 in total

1.  Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo.

Authors:  Rizia Bardhan; Wenxue Chen; Marc Bartels; Carlos Perez-Torres; Maria F Botero; Robin Ward McAninch; Alejandro Contreras; Rachel Schiff; Robia G Pautler; Naomi J Halas; Amit Joshi
Journal:  Nano Lett       Date:  2010-11-22       Impact factor: 11.189

Review 2.  Aberrant PSA glycosylation--a sweet predictor of prostate cancer.

Authors:  Sarah Gilgunn; Paul J Conroy; Radka Saldova; Pauline M Rudd; Richard J O'Kennedy
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.